Khanani AM, Kotecha A, Chang A, Chen SJ, et al. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2. Ophthalmology 2024;131:914-926.
PMID: 38382813